Elevated levels of interleukin-6 in serum and cerebrospinal fluid of HTLV-I-associated myelopathy/tropical spastic paraparesis

[1]  S. Nagataki,et al.  LONG-TERM FOLLOW-UP OF IMMUNOMODULATION IN TREATMENT OF HTLV-I-ASSOCIATED MYELOPATHY , 1989, The Lancet.

[2]  T. Hirano,et al.  Elevation of serum interleukin 6 prior to acute phase proteins on the inflammation by surgical operation. , 1989, Clinical immunology and immunopathology.

[3]  T. Hirano,et al.  Induction of IL-6 (B cell stimulatory factor-2/IFN-beta 2) production by HIV. , 1989, Journal of immunology.

[4]  T. Hirano,et al.  IL-6/BSF-2 functions as a killer helper factor in the in vitro induction of cytotoxic T cells. , 1988, Journal of immunology.

[5]  T. Matsuda,et al.  Establishment of an interleukin 6 (IL 6)/B cell stimulatory factor 2‐dependent cell line and preparation of anti‐IL 6 monoclonal antibodies , 1988, European journal of immunology.

[6]  J. Sninsky,et al.  Detection of human T-cell lymphoma/leukemia virus type I DNA and antigen in spinal fluid and blood of patients with chronic progressive myelopathy. , 1988, The New England journal of medicine.

[7]  Y. Itoyama,et al.  Altered subsets of peripheral blood lymphocytes in patients with HTLV‐I associated myelopathy (HAM) , 1988, Neurology.

[8]  C. Uyttenhove,et al.  T cell growth and differentiation induced by interleukin-HP1/IL-6, the murine hybridoma/plasmacytoma growth factor , 1988, The Journal of experimental medicine.

[9]  M. Osame,et al.  IDENTITY OF HTLV-I-ASSOCIATED TROPICAL SPASTIC PARAPARESIS AND HTLV-I-ASSOCIATED MYELOPATHY , 1988, The Lancet.

[10]  T. Hirano,et al.  B cell stimulating factor 2/interleukin 6 is a costimulant for human thymocytes and T lymphocytes , 1988, The Journal of experimental medicine.

[11]  D. McFarlin,et al.  Isolation of an HTLV-1-like retrovirus from patients with tropical spastic paraparesis , 1988, Nature.

[12]  P. Sehgal,et al.  Monocyte-derived human B-cell growth factor identified as interferon-beta 2 (BSF-2, IL-6). , 1988, Science.

[13]  S. Clark,et al.  B cell stimulatory factor-2 is involved in the differentiation of cytotoxic T lymphocytes. , 1988, Journal of immunology.

[14]  S. Clark,et al.  B-cell-stimulatory factor 2 (beta 2 interferon) functions as a second signal for interleukin 2 production by mature murine T cells. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[15]  P. Lansdorp,et al.  Interferon beta 2/B-cell stimulatory factor type 2 shares identity with monocyte-derived hepatocyte-stimulating factor and regulates the major acute phase protein response in liver cells. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[16]  T. Hirano,et al.  Enhancement of the interleukin 2 receptor expression on T cells by multiple B-lymphotropic lymphokines. , 1987, Immunology letters.

[17]  E. Tournier-Lasserve,et al.  IL-2 receptor and HLA class II antigens on cerebrospinal fluid cells of patients with multiple sclerosis and other neurological diseases. , 1987, Clinical and experimental immunology.

[18]  S. Izumo,et al.  Chronic progressive myelopathy associated with elevated antibodies to human T‐lymphotropic virus type I and adult T‐cell leukemialike cells , 1987, Annals of neurology.

[19]  G. de‐Thé,et al.  Endemic tropical spastic paraparesis associated with human T‐lymphotropic virus type I: A clinical and seroepidemiological study of 25 cases , 1987, Annals of neurology.

[20]  M. Setoguchi,et al.  NECROPSY FINDINGS IN HTLV-I ASSOCIATED MYELOPATHY , 1987, The Lancet.

[21]  T. Taniguchi,et al.  Complementary DNA for a novel human interleukin (BSF-2) that induces B lymphocytes to produce immunoglobulin , 1986, Nature.

[22]  Y. Ohtsuki,et al.  ISOLATION OF HTLV-I FROM CEREBROSPINAL FLUID OF A PATIENT WITH MYELOPATHY , 1986, The Lancet.

[23]  Mitsuhiro Osame,et al.  HTLV-I ASSOCIATED MYELOPATHY, A NEW CLINICAL ENTITY , 1986, The Lancet.

[24]  D. Gajdusek,et al.  HTLV-I AND HTLV-III ANTIBODIES AND TROPICAL SPASTIC PARAPARESIS , 1985, The Lancet.

[25]  R. Gallo.  The human T-cell leukemia/lymphotropic retroviruses (HTLV) family: past, present, and future. , 1985, Cancer research.

[26]  F. Barin,et al.  ANTIBODIES TO HUMAN T-LYMPHOTROPIC VIRUS TYPE-I IN PATIENTS WITH TROPICAL SPASTIC PARAPARESIS , 1985, The Lancet.

[27]  A. Fauci,et al.  Alteration of T-cell functions by infection with HTLV-I or HTLV-II. , 1984, Science.

[28]  T. Kishimoto,et al.  Isolation and characterization of B cell differentiation factor (BCDF) secreted from a human B lymphoblastoid cell line. , 1984, Journal of immunology.

[29]  T. Hirano,et al.  Molecular regulation of B lymphocyte response. , 1988, Annual review of immunology.

[30]  M. Dalakas,et al.  Tropical spastic paraparesis: Clinical, immunological, and virological studies in two patients from martinique , 1988, Annals of neurology.

[31]  D. McFarlin,et al.  Immunological findings in neurological diseases associated with antibodies to HTLV‐I: Activated lymphocytes in tropical spastic paraparesis , 1988, Annals of neurology.

[32]  I. Kitajima,et al.  Immunological studies of HTLV-I associated myelopathy. , 1988, Autoimmunity.

[33]  J. Oger,et al.  Cell-mediated immune functions in multiple sclerosis. , 1987, Pathology and Immunopathology Research.

[34]  M. Feldmann,et al.  The distribution of interleukin-2 receptor bearing lymphocytes in multiple sclerosis: evidence for a key role of activated lymphocytes. , 1985, Clinical and experimental immunology.